News and Events

Latest News

Arquer Diagnostics @Arquer Diagnostics
Hello #Venice! #Arquer Diagnostics and #Pantec SRL are in attendance at the 92nd Annual Italian #Urology Congress. https://t.co/FhOvCtBxtO https://t.co/XCqoUQcLMt

- 7 days ago

1 2
Arquer Diagnostics @Arquer Diagnostics
99.5% is the measure of the ability of our #ADXBLADDER technology to exclude the presence of a bladder cancer tumour (excl. non LGpTa). Find out more about how we're helping #urology and #cancerpatients worldwide: https://t.co/FhOvCtBxtO #Arquer https://t.co/za2WQF270r

- 18 days ago

2 5
Arquer Diagnostics @Arquer Diagnostics
If a #patient refuses a #cystoscopy, there are other options. Our #ADXBLADDER can exclude the presence of #bladdercancer (99.5% NPV for non LGpTa #tumours), without unpleasant testing. https://t.co/FhOvCtBxtO https://t.co/t7oBWgHsuY

- 27 days ago

3 2
Arquer Diagnostics @Arquer Diagnostics
856 patients were enrolled in our multicentre #clinicalstudy of #ADXBLADDER, which can exclude the presence of non-LGpTa #bladdercancer tumours in 98.9% of cases. #Arquer #ArquerDX #ADXBLADDER #ArquerDiagnostics #health https://t.co/IyWWxYcEm8

- 39 days ago

3 2
Arquer Diagnostics @Arquer Diagnostics
With the ability to accurately rule out high-grade #tumours in 98.9% of cases, #ADXBLADDER could replace cytology, offering premium #diagnostic solutions to #urologists and patients alike. #Arquer #ArquerDX #ADXBLADDER #ArquerDiagnostics #health https://t.co/Y4m8v548yY

- 48 days ago

3 3
arquer diagnostics

Innovation That Never Sleeps

The Start of Non-Invasive Testing When Arquer Diagnostics was set up to research and develop a new innovative urine test ...
Read More

Arquer Diagnostics achieves ISO13485 certification from BSI

In alignment with its commitment to achieving and maintaining excellence for patients, clinicians and all partners. BSI is an internationally ...
Read More

ADXBLADDER: A Novel Non-Invasive Aid for Bladder Cancer Monitoring

The innovative Arquer Diagnostic urine test for bladder cancer adds recurrence monitoring to the approved indications Sunderland, January 22nd 2019 ...
Read More

Arquer CEO Nadia Whittley Named Among Top 50 Female ‘Movers & Shakers’ in BioBusiness Report

Arquer Diagnostics Ltd (“Arquer”), a UK-based company focusing on the development of non-invasive cancer diagnostic tests today announced that CEO ...
Read More